News

Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Kairos Pharma and Bayer to evaluate ENV-105 combination in prostate cancer
read more
Advanced Therapies,Biotech & Pharma Business,Drug Delivery & Formulation,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics
Lonza expands ADC drug product capacity in Switzerland
read more
Central Nervous System,Research & Development
Brain network dynamics may better explain psychiatric symptoms than diagnoses
read more
Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
India’s CDMO market needs science, not just scale, says Lupin Manufacturing Solutions CEO
read more
Central Nervous System,Digital & Data,Medical devices
Natus expands AI-powered EEG analysis across Europe
read more
Advanced Therapies,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Telix starts Phase 3 trial of radiopharmaceutical therapy for renal cancer
read more
Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Deep Origin computational platform identifies potent molecular glue for lymphoma treatment
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics,Research & Development
Samsung Biologics to acquire PolyPeptide in $1.46bn deal
read more
Digital & Data,Manufacturing & Supply Chain,Research & Development
Omniflex deploys cold chain monitoring system across 17 South African research sites
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
EMA accepts Almirall application to extend Ebglyss use in young children with atopic dermatitis
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects
read more
Biotech & Pharma Business,Clinical & Regulatory,Research & Development
Mission Therapeutics signs US$292M deal for acute kidney injury programme
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Medicus receives FDA feedback and IRB approval for Teverelix Phase 2 urinary retention trial
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development
Compass Pathways study explores monitoring and support in COMP360 PTSD trial
read more
Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas
NEJM study provides first clinical evidence for NET-degrading therapy in lupus
read more

Kairos Pharma and Bayer to evaluate ENV-105 combination in prostate cancer

Lonza expands ADC drug product capacity in Switzerland

Brain network dynamics may better explain psychiatric symptoms than diagnoses

India’s CDMO market needs science, not just scale, says Lupin Manufacturing Solutions CEO

Natus expands AI-powered EEG analysis across Europe

Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma

Telix starts Phase 3 trial of radiopharmaceutical therapy for renal cancer

Deep Origin computational platform identifies potent molecular glue for lymphoma treatment

Samsung Biologics to acquire PolyPeptide in $1.46bn deal

Omniflex deploys cold chain monitoring system across 17 South African research sites

EMA accepts Almirall application to extend Ebglyss use in young children with atopic dermatitis

Ten-year NHS study supports focal therapy for prostate cancer with fewer side effects

Mission Therapeutics signs US$292M deal for acute kidney injury programme

Medicus receives FDA feedback and IRB approval for Teverelix Phase 2 urinary retention trial

Compass Pathways study explores monitoring and support in COMP360 PTSD trial

NEJM study provides first clinical evidence for NET-degrading therapy in lupus

main menu

recent posts

Karyopharm seeks FDA accelerated approval for selinexor in myelofibrosis

Evonik invests €93M in new GMP LNP manufacturing facility

Kazia reports 83% response rate for paxalisib in triple-negative breast cancer

get connected